Ertapenem Sodium
Brand name: Ertapenem
Rank #427 of 500 drugs by total cost
$19.4M
Total Cost
36,784
Total Claims
$19.4M
Total Cost
1,474
Prescribers
$528
Cost per Claim
6,725
Beneficiaries
36,787
30-Day Fills
$13K
Avg Cost/Provider
25
Avg Claims/Provider
About Ertapenem Sodium
Ertapenem Sodium (sold as Ertapenem) was prescribed 36,784 times by 1,474 Medicare Part D providers in 2023, costing the program $19.4M. At $528 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 424 | Brinzolamide (Azopt) | $20.1M | 57,322 |
| 425 | Clobazam (Clobazam) | $19.8M | 58,877 |
| 426 | Fluorouracil (Fluorouracil) | $19.5M | 220,445 |
| 427 | Ertapenem Sodium (Ertapenem) | $19.4M | 36,784 |
| 428 | Sumatriptan Succinate (Sumatriptan Succinate) | $19.4M | 555,011 |
| 429 | Darbepoetin Alfa In Polysorbat (Aranesp) | $19.3M | 6,889 |
| 430 | Ondansetron Hcl (Ondansetron Hcl) | $19.3M | 1,255,548 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology